European Commission reaches deal for Covid-19 treatment drug

Thu, 08 Oct, 2020 - 12:42

Associated Press

The European Commission says it has sealed a deal with pharmaceutical company Gilead to buy 500,000 treatment courses of remdesivir.

No treatment has yet proved able to prevent serious illness after a coronavirus infection, but the antiviral drug also known by its commercial name Veklury has helped some Covid-19 patients recover faster.

CONNECT WITH US TODAY

NEWSLETTERS

NOTIFICATIONS

Be the first to know the latest news and updates

Ireland's Covid review is not public inquiry and 'not here to point fingers', chair says

CSO launches survey to assess impact of Covid-19 pandemic on public

Chairwoman appointed to lead Irish Covid-19 probe

More in this section

FBI ‘unaware of Savannah Guthrie talking with her mother’s suspected kidnappers’

Lord Peter Mandelson Epstein files scandal

Keir Starmer says he is ‘not prepared to walk away’ after call for resignation

Scottish labour leader calls for Keir Starmer's resignation over Mandelson scandal

Coronavirus Remdesivir Place: International

<p>The couple, who were part of a small group of diplomats facilitating the 1993-1995 Oslo accords, are the latest heavyweight Norwegians to make the headlines over the Epstein files.</p>

Two senior Norwegian diplomats being investigated over Epstein links

READ NOW

European Commission reaches deal for Covid-19 treatment drug

Subscribe to access all of the Irish Examiner.

Two senior Norwegian diplomats being investigated over Epstein links

Latest

Most Read